Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Juan Ospina Idarraga"'
Autor:
Denisse Castro, Jorge J. Castillo, Ivan Perdomo, Efreen Montaño Figueroa, Cristobal Augusto Frutos Ortiz, Humberto Martínez Cordero, Mercedes Royg Arriola, Brady E Beltran, Alana Von Glasenapp, Gladys P. Agreda-Vásquez, Eduardo M. Sotomayor, Marcos Distefano, Guillermo J. Ruiz-Argüelles, Camila Peña, Katerine Garcia, Lidiane Andino, Lorena Fiad, Maria Elvira Enciso, Cristaldo Nancy, Carolina Feres, Maria Virginia Prates, Rosio Baena, Henry Idrobo, Sally Rose Paredes, Virginia Otero, Fabiola Valvert, Daniela Zambrano, Luis Villela Villela, Maria Elena Cabrera, Luis E Malpica Castillo, Alfredo Reinaldo Quiroz, Melani Otañez, Juan Ospina Idarraga, Myrna Candelaria, Juan Antonio Choque, Maria Alejandra Torres Viera, Magali DelosRios, Mariana Kalmus, Fernando Perez-Jacobo, Guilherme Fleury Perini, Ana Florencia Ramirez-Ibarguen, Julian Cordova, David Gómez-Almaguer, María Lorena Cardozo, Eloisa Riva
Publikováno v:
Blood. 136:25-27
Introduction. There are different scoring systems to differentiate risk groups in patients with DLBCL treated with chemoimmunotherapy. Those systems have used the same 5 variables (age, performance status, LDH, stage, extranodal involvement) for 27 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d2b7800117f8ba7e681b0bd3f194929
https://doi.org/10.1182/blood-2020-142836
https://doi.org/10.1182/blood-2020-142836
Autor:
Dorotea Fantl, Natalia Schutz, Judith Pineda, Sofia Sanchez, Humberto Martínez Cordero, Ramiro Espinoza, Camila Peña, Luara L Arana-Luna, Evelyn Herrera, María Eugenia Espitia, Alana Von Glasenapp, Cristian Seehaus, Eloisa Riva, Christine Rojas, José Antonio de la Peña-Celaya, Aline Ramirez Alvarado, Juan Manuel Mancilla Díaz Rodrigo Erick Escartín Pérez, Guillermo José Ruiz Argüelles, Guillermina Remaggi, Eleazar Ramírez Hernández, Henry Idrobo, Andrea Noboa, Lina Moreno Gómez, Martha Alvarado, Lourdes David Salas, Virginia Abello, Juan Ospina Idarraga
Publikováno v:
Blood
Background The SARS CoV-2 / COVID 19 pandemic has challenged the world's health systems, especially services that treat cancer. The first studies in China showed that cancer patients had a higher risk of becoming infected and dying. Other risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc2c0133b203a98c8e221ecdfb4a867
https://doi.org/10.1182/blood-2020-142823
https://doi.org/10.1182/blood-2020-142823
Autor:
Efreen Montaño Figueroa, Eduardo M. Sotomayor, Victoria Otero, Juan Antonio Choque, Claudia Gajardo, Christine Rojas, Cristaldo Nancy, Luis Villela Villela, Camila Peña, Rosio Baena, Mariana Kalmus, Sofia Sanchez, Guilherme Fleury Perini, Sally Rose Paredes, Juan Felipe Lasso, Denisse Castro, Virginia Abello, Luis Malpica Castillo, Juan Ospina Idarraga, Larissa Lc Teixeira, Fernando Pérez-Jacobo, Melani Otañez, Brady E Beltran, Alana Von Glasenapp, Carolina Feres, Maria Alejandra Torres Viera, Marcos Di Stefano, Ivan Perdomo, Daniela Zambrano, Macarena Alejandra Roa Salinas, Ana Florencia Ramirez-Ibarguen, Ximena Valladares, Andrea Noboa, Lorena Fiad, Henry Idrobo, Fabiola Valvert, Jorge J. Castillo, Myrna Candelaria, Humberto Martínez Cordero, Maria Virginia Prates
Publikováno v:
Blood
Introduction: SARS-COV-2 pandemic has infected approximately 20 million people worldwide and more than 700.000 fatalities have been reported. Patients with malignant hematological diseases are at particular risk for unfavorable outcomes, including in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fcd5cc9cf95124ac504ef36e429b6a2
http://europepmc.org/articles/PMC8330353
http://europepmc.org/articles/PMC8330353
Autor:
Guillermo José Ruiz Argüelles, Henry Idrobo, Manuel Antonio Granja Morá, Macarena Roa, Juan Ospina Idarraga, Carlos Fernández de Larrea, Lina María Martínez, Fiorella Villano, Humberto Martinez-Codero, Marcela Zamora, Virginia Bove, Dorotea Fantl, Natalia Schutz, Virginia Abello Polo, Eloisa Riva, Camila Peña Ojeda, Rosa Olday Ríos Jiménez
Publikováno v:
Revista Colombiana de Cancerología. 24
La enfermedad por COVID-19 fue detectada a finales de 2019 en Wuhan, China. Debido a su rápida propagación fue declarada emergencia sanitaria de forma inicial y luego de identificar casos fuera de China con transmisión autóctona y caracterizado p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e1b652db1b95b75f943227c1343ca9
https://doi.org/10.35509/01239015.656
https://doi.org/10.35509/01239015.656
Autor:
Maria Elena Cabrera, Carlos Best, Guilherme Fleury Perini, Juan Ospina Idarraga, Erick Bichara, Henry Idrobo, Ana Carolina Oliver, Sally Rose Paredes, Maria Alejandra Luna, Fabiola Valvert, Vera Larissa Cordero-Moreno, Cristaldo Nancy, Karen Lilian Bonfil, Luis Villela, Jorge J. Castillo, Yusaima Rodriguez, Larissa Lane Cardoso, Efreen Montaño Figueroa, Camila Peña, Luis Malpica Castillo, Rosio Baena, Macarena Roa, Humberto Martinez-Cordero, Myrna Candelaria, María Victoria Irigoín, Melani Otañez, Claudia Gajardo, Lorena Fiad, Ana Florencia Ramirez-Ibarguen, Denisse Castro, Victoria Otero, Marialejandra Torres Viera, Rosa Oliday Rios, Jose Macias, Brady E Beltran, Alana Von Glasenapp, Catalina Díaz, Maria Virginia Prates, Carmen Lome, Fernando Pérez-Jacobo, Bryan Valcarcel
Publikováno v:
Blood. 138:2516-2516
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma subtype. Early stage (I/II) disease is seen in up to 30% of all DLBCL cases, and although outcomes in this subgroup have been reported as optimal, relapses can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3e65d974030290a054f225157f59e2
https://doi.org/10.1182/blood-2021-152724
https://doi.org/10.1182/blood-2021-152724
Autor:
Alejandro Rico Mendoza, Henry Idrobo, Lorena Cubillos Osorio, Juan Ospina Idarraga, Leonardo Bautista Toloza, Viviana Olaya, Humberto Martínez Cordero, Alexandra Porras Ramírez, Juan Manuel Herrera, Sergio Andres Cancelado, Kenny Galvez, Jessica Zapata Malagon
Publikováno v:
Blood. 136:10-11
Background Multiple myeloma (MM) is a heterogeneous and incurable disease that evolves from asymptomatic premalignant conditions. The worldwide incidence, prevalence and mortality are well known thanks to data reported by the International Agency for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcc2a2c7ce42209b52bf07344ea68f9
https://doi.org/10.1182/blood-2020-142376
https://doi.org/10.1182/blood-2020-142376
Autor:
Juan Ospina Idarraga, Alejandro Rico Mendoza, Lina Martinez Correa, Henry Idrobo, Jenifer Buitrago, Xiomara Castañeda Contreras, Alexandra Porras Ramírez, Humberto Martínez Cordero
Publikováno v:
Blood. 136:38-39
Background Acute promyelocytic leukemia (APL) is a malignant hematologic disease with a high cure rate, but unfortunately it produces several serious complications at the onset of the disease that explain the high early mortality. Based on clinical e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6eb9a7da421cfd81667004bcb45ab59f
https://doi.org/10.1182/blood-2020-143191
https://doi.org/10.1182/blood-2020-143191
Autor:
Laura Silva Idárraga, Luis Malpica Castillo, Humberto Martínez Cordero, Brady E Beltran, Melani Otañez, Claudia Gajardo, Fernando Pérez-Jacobo, Camila Peña, Alana Von Glasenapp, Catalina Díaz, Juan Ospina Idarraga, Denisse Castro, Guilherme Fleury Perini, Eduardo M. Sotomayor, Ana Florencia Ramirez-Ibarguen, Efreen Montaño Figueroa, Luis Villela Villela, Macarena Alejandra Roa Salinas, Sally Rose Paredes, Maria Elena Cabrera, Marcos Di Stefano, Virginia Abello, Victoria Otero, Rosio Baena, Juan Antonio Choque, Cristaldo Nancy, Maria Virginia Prates, Ivan Perdomo, Jorge J. Castillo, Lorena Fiad, Henry Idrobo, Fabiola Valvert, Myrna Candelaria, Maria Alejandra Torres Viera
Publikováno v:
Blood. 136:12-13
Introduction: Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma subtype seen in Western countries. However, data on FL from Latin America (LATAM) are scarce. We aimed at better understanding the clinical features, treatment pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58e2a68f4ff1da1c4004cbf6315f0329
https://doi.org/10.1182/blood-2020-141943
https://doi.org/10.1182/blood-2020-141943